Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miyake

Showing results (71-80 of 14,543) with videos related to

Pageof 1,455
Sort By:
Seikagaku. the Journal of Japanese Biochemical Society|March 25, 1975
[In vivo study on methylation of tissue proteins and degradation of methylated proteins (author's transl)]M Miyake
Journal of Experimental Psychology. General|June 21, 2001
Individual differences in working memory: introduction to the special sectionA Miyake
Biological & Pharmaceutical Bulletin|November 6, 2019
Estimating Efflux Transporter-Mediated Disposition of Molecules beyond the Rule of Five (bRo5) Using Transporter Gene Knockout RatsTaiji Miyake
The Japanese Journal of Antibiotics|January 1, 1977
[Memories of the late Dr. Koichi Ogata]A Miyake
Antioxidants (Basel, Switzerland)|March 15, 2020
Molecular Mechanism of Oxidation of P700 and Suppression of ROS Production in Photosystem I in Response to Electron-Sink Limitations in C3 PlantsChikahiro Miyake
Masui. the Japanese Journal of Anesthesiology|February 1, 1988
[Active oxygen and oxidative stress]T Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 14, 2022
Editorial Comment to Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinomaMakito Miyake
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2019
[Ⅰ. Are There Any Changes in the Epidemiological Trends in Renal Cell Carcinoma in Japan ?]Hideaki Miyake
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Ⅱ. Clinical Evidence and Biological Mechanism of BCG Failure in Patients with Non-Muscle Invasive Bladder Cancer]Makito Miyake
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|June 1, 1981
[Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)]M Miyake
Pageof 1,455

Showing results (71-80 of 14,543) with videos related to

Sort By:
Pageof 1,455
Seikagaku. the Journal of Japanese Biochemical Society|March 25, 1975
[In vivo study on methylation of tissue proteins and degradation of methylated proteins (author's transl)]M Miyake
Journal of Experimental Psychology. General|June 21, 2001
Individual differences in working memory: introduction to the special sectionA Miyake
Biological & Pharmaceutical Bulletin|November 6, 2019
Estimating Efflux Transporter-Mediated Disposition of Molecules beyond the Rule of Five (bRo5) Using Transporter Gene Knockout RatsTaiji Miyake
The Japanese Journal of Antibiotics|January 1, 1977
[Memories of the late Dr. Koichi Ogata]A Miyake
Antioxidants (Basel, Switzerland)|March 15, 2020
Molecular Mechanism of Oxidation of P700 and Suppression of ROS Production in Photosystem I in Response to Electron-Sink Limitations in C3 PlantsChikahiro Miyake
Masui. the Japanese Journal of Anesthesiology|February 1, 1988
[Active oxygen and oxidative stress]T Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 14, 2022
Editorial Comment to Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinomaMakito Miyake
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2019
[Ⅰ. Are There Any Changes in the Epidemiological Trends in Renal Cell Carcinoma in Japan ?]Hideaki Miyake
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Ⅱ. Clinical Evidence and Biological Mechanism of BCG Failure in Patients with Non-Muscle Invasive Bladder Cancer]Makito Miyake
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|June 1, 1981
[Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)]M Miyake
Pageof 1,455